April 18, 2007 - RxHub LLC announced that its network solutions, which can help make electronic prescribing possible for 160 million Americans, the Certification Commission for Healthcare Information Technology (CCHIT) has selected RxHub as one of the networks that will assist CCHIT in the validation of electronic prescribing related criteria.

CCHIT is a recognized certification body (RCB) in the U.S. for certifying health information technology products - an independent, nonprofit organization that tests electronic health records (EHRs) against criteria for functionality, interoperability and security.

ePrescribing is a key building block for EHRs. It provides patients' medication history and formulary and benefit information, which can be fed directly into patients' individual electronic health records because the two systems are interoperable. RxHub is a key piece of today's ePrescribing infrastructure, providing a standard communication "hub" where ePrescribing information can be exchanged accurately, safely and securely in a matter of seconds among all participating parties in the prescription delivery process. This includes physicians and other prescribers, health plans, pharmacy benefit managers, and pharmacies. RxHub network solutions cover nearly two out of three Americans.

RxHub will work with CCHIT and technology vendors to ensure that ePrescribing information can be exchanged correctly and securely with ambulatory EHRs pursuing CCHIT certification. This CCHIT "seal of approval" indicates that EHR products have successfully undergone standards-based testing for functionality, interoperability and security. By looking to EHRs with the CCHIT Certified seal, physicians and other providers can be assured that the technologies meet expected industry standards.

Mr. Little additionally noted that providing ePrescribing information to EHRs will increase patient safety and quality of care by reducing medication errors created in today's paper process by illegible handwriting and transcription mistakes. It also will provide more complete information at the point of care on patients' medical problems and medications they may be receiving from multiple providers. This in turn will help eliminate duplicate prescriptions and result in prescriptions that are potentially cheaper and more therapeutically appropriate.


Related Content

News | Image Guided Radiation Therapy (IGRT)

June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...

Time June 07, 2022
arrow
News | Image Guided Radiation Therapy (IGRT)

May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...

Time May 19, 2022
arrow
News | Radiation Oncology

August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...

Time August 27, 2021
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Image Guided Radiation Therapy (IGRT)

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...

Time February 11, 2020
arrow
News | Radiology Imaging

December 12, 2019 — Philips and the Regional Medical Center (RMC) announced a strategic 5-year partnership agreement ...

Time December 12, 2019
arrow
News | Radiation Therapy

October 22, 2019 — The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) ...

Time October 22, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac System at Dana-Farber/Brigham and Women's Cancer Center. The MRIdian provides for the delivery of radiation therapy to targeted tumors while simultaneously providing continuous magnetic resonance imaging (MRI).

Time October 08, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.

Time September 16, 2019
arrow
Subscribe Now